Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
No open-market purchases or sales by Processa Pharmaceuticals, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 18 | 22 | +4 |
| Shares | 1.16M | 1.65M | +489.3K (+42.1%) |
| Value | $1.28M | $852.6K | −$424.3K (−33.2%) |
New holders (8)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 733,954 | $388.9K | 0.01% |
| Two Sigma Securities, LLC | 62,626 | $31.3K | 0.00% |
| Millennium Management LLC | 50,504 | $27.0K | 0.00% |
| UBS Group AG | 22,459 | $11.2K | 0.00% |
| Virtu Financial LLC | 12,949 | $7.00K | 0.00% |
| Jane Street Group, LLC | 10,040 | $5.02K | 0.00% |
| WealthPLAN Partners, LLC | 1,000 | $500 | 0.00% |
| Farther Finance Advisors, LLC | 487 | $244 | 0.00% |
Sold out (4)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| AIGH Capital Management LLC | 303,703 | $334.1K |
| Worth Venture Partners, LLC | 70,954 | $78.0K |
| Royal Bank of Canada | 1,000 | $1.00K |
| Bank of America Corp | 14 | $15 |